Company profile: Formulated Solutions
1.1 - Company Overview
Company description
- Provider of contract development and manufacturing services for RX therapeutics, OTC products, medical devices, and personal care. Offers process development and engineering from pre-clinical to GMP scale, flexible manufacturing, lab, regulatory, distribution and marketing support, and platform innovation in raw material chemistries and packaging for consumer healthcare, including ZnOSpray, eN2fused, and cryO2fused delivery technologies.
Products and services
- Manufacturing: Applies flexible, industrial-grade manufacturing processes across RX therapeutics, OTC, medical devices, and personal care to ensure product quality and consistency during production
- Process Development & Engineering: Engineers end-to-end process formalization for seamless scale-up from pre-clinical to GMP lab scale, enabling commercialization with controlled transfer from development to production
- Platform Innovation: Creates custom-engineered raw material chemistries and packaging technologies for consumer healthcare products, co-developing novel components with partners to enhance application formats and product performance
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Formulated Solutions
BioTalent
HQ: United Kingdom
Website
- Description: Provider of life sciences recruitment services with international reach, knowledge and expertise. Also operates BioTalent Social, an event and networking platform that creates and hosts life sciences networking and knowledge-building events, featuring wide-ranging discussions led by a panel of market-leading experts.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioTalent company profile →
Lyophilization Services
HQ: United States
Website
- Description: Provider of lyophilization services to the pharmaceutical, biotechnology, and medical device industries, producing products in a timely, reliably consistent, GMP-compliant manner with a focus on quality and patient safety.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lyophilization Services company profile →
Icagen
HQ: United States
Website
- Description: Provider of ion channel-focused drug discovery platforms and services, including the Ion Channel Technology combining novel reagent generation, advanced biophysical analysis, and in silico tools; discovery-to-lead optimization services; and partnering with pharma/biotech to advance orally administered small-molecule therapeutics in neuroscience and chronic kidney disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Icagen company profile →
Inno4Life
HQ: The Netherlands
Website
- Description: Provider of complex customer-specific equipment and services for life science industries, primarily pharmaceuticals (human and animal), medical and clinical instrumentation, and food.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Inno4Life company profile →
Syrrx
HQ: United States
Website
- Description: Provider of drug discovery services leveraging high-throughput structural biology, focusing on drug targets validated in human clinical trials and directing efforts toward therapeutics for metabolic diseases, cancer, and inflammation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Syrrx company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Formulated Solutions
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Formulated Solutions
2.2 - Growth funds investing in similar companies to Formulated Solutions
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Formulated Solutions
4.2 - Public trading comparable groups for Formulated Solutions
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →